The Next Generation Sequencing (NGS) Market is projected to reach $27.5 billion by 2030, with a compound annual growth rate (CAGR) of 15.8% during the forecast period, according to Meticulous Research®. NGS is a cutting-edge technology for sequencing nucleotides in genetic material, allowing for quicker and more cost-effective DNA and RNA sequencing compared to traditional Sanger sequencing.